The Links between ALS and NF-κB
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease wherein motor neuron degeneration leads to muscle weakness, progressive paralysis, and death within 3-5 years of diagnosis. Currently, the cause of ALS is unknown but, as with several neurodegenerative diseases, the potential role of...
Gespeichert in:
Veröffentlicht in: | International journal of molecular sciences 2021-04, Vol.22 (8), p.3875 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 8 |
container_start_page | 3875 |
container_title | International journal of molecular sciences |
container_volume | 22 |
creator | Källstig, Emma McCabe, Brian D Schneider, Bernard L |
description | Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease wherein motor neuron degeneration leads to muscle weakness, progressive paralysis, and death within 3-5 years of diagnosis. Currently, the cause of ALS is unknown but, as with several neurodegenerative diseases, the potential role of neuroinflammation has become an increasingly popular hypothesis in ALS research. Indeed, upregulation of neuroinflammatory factors have been observed in both ALS patients and animal models. One such factor is the inflammatory inducer NF-κB. Besides its connection to inflammation, NF-κB activity can be linked to several genes associated to familial forms of ALS, and many of the environmental risk factors of the disease stimulate NF-κB activation. Collectively, this has led many to hypothesize that NF-κB proteins may play a role in ALS pathogenesis. In this review, we discuss the genetic and environmental connections between NF-κB and ALS, as well as how this pathway may affect different CNS cell types, and finally how this may lead to motor neuron degeneration. |
doi_str_mv | 10.3390/ijms22083875 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8070122</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2548685941</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-cb9353272ca37e9b0e09ad8ddcb9fd7f7cc1b67f6dccec538237a6c1fc4035e13</originalsourceid><addsrcrecordid>eNpdkMFOwzAQRC0EoqVw44wiceFAwF4nsXNBKhUFpAgOlLPlOBua0iQlTkD8Gh_BN-GqpSqcdqV9O5oZQo4ZveA8ppfFrLQAVHIpwh3SZwGAT2kkdrf2HjmwdkYpcAjjfdJzj0zSGPrEm0zRS4rq1Xopth-IlTdMnjxdZd7D2P_-uj4ke7meWzxazwF5Ht9MRnd-8nh7PxomvgkYtL5JYx5yEGA0FxinFGmsM5ll7pBnIhfGsDQSeZQZgybkErjQkWG5CSgPkfEBuVrpLrq0xMxg1TZ6rhZNUermU9W6UH8vVTFVL_W7klRQBuAEztYCTf3WoW1VWViD87musO6sgtCVFIHgwqGn_9BZ3TWVi-eoQEYyjIOlo_MVZZra2gbzjRlG1bJ6tV29w0-2A2zg3675D75afk4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2548685941</pqid></control><display><type>article</type><title>The Links between ALS and NF-κB</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Källstig, Emma ; McCabe, Brian D ; Schneider, Bernard L</creator><creatorcontrib>Källstig, Emma ; McCabe, Brian D ; Schneider, Bernard L</creatorcontrib><description>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease wherein motor neuron degeneration leads to muscle weakness, progressive paralysis, and death within 3-5 years of diagnosis. Currently, the cause of ALS is unknown but, as with several neurodegenerative diseases, the potential role of neuroinflammation has become an increasingly popular hypothesis in ALS research. Indeed, upregulation of neuroinflammatory factors have been observed in both ALS patients and animal models. One such factor is the inflammatory inducer NF-κB. Besides its connection to inflammation, NF-κB activity can be linked to several genes associated to familial forms of ALS, and many of the environmental risk factors of the disease stimulate NF-κB activation. Collectively, this has led many to hypothesize that NF-κB proteins may play a role in ALS pathogenesis. In this review, we discuss the genetic and environmental connections between NF-κB and ALS, as well as how this pathway may affect different CNS cell types, and finally how this may lead to motor neuron degeneration.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms22083875</identifier><identifier>PMID: 33918092</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Alleles ; Alzheimer's disease ; Amyotrophic lateral sclerosis ; Amyotrophic Lateral Sclerosis - etiology ; Amyotrophic Lateral Sclerosis - metabolism ; Amyotrophic Lateral Sclerosis - pathology ; Animal models ; Animals ; Biomarkers ; Cytokines ; Degeneration ; Disease Susceptibility ; Environment ; Enzyme Activation ; Gene expression ; Genetic Predisposition to Disease ; Genetic Variation ; Humans ; Immune system ; Infections ; Inflammation ; Kinases ; Localization ; Microglia - metabolism ; Microglia - pathology ; Muscles ; Nervous system ; Neurodegeneration ; Neuromuscular diseases ; Neurons ; Neurons - metabolism ; Neurons - pathology ; NF-kappa B - metabolism ; NF-κB protein ; Oligodendroglia - metabolism ; Oligodendroglia - pathology ; Paralysis ; Proteins ; Review ; Risk analysis ; Risk factors ; Roles ; Tumor necrosis factor-TNF ; Viral infections</subject><ispartof>International journal of molecular sciences, 2021-04, Vol.22 (8), p.3875</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-cb9353272ca37e9b0e09ad8ddcb9fd7f7cc1b67f6dccec538237a6c1fc4035e13</citedby><cites>FETCH-LOGICAL-c412t-cb9353272ca37e9b0e09ad8ddcb9fd7f7cc1b67f6dccec538237a6c1fc4035e13</cites><orcidid>0000-0003-1620-0501 ; 0000-0001-5485-8748 ; 0000-0002-2282-5690</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070122/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070122/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33918092$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Källstig, Emma</creatorcontrib><creatorcontrib>McCabe, Brian D</creatorcontrib><creatorcontrib>Schneider, Bernard L</creatorcontrib><title>The Links between ALS and NF-κB</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease wherein motor neuron degeneration leads to muscle weakness, progressive paralysis, and death within 3-5 years of diagnosis. Currently, the cause of ALS is unknown but, as with several neurodegenerative diseases, the potential role of neuroinflammation has become an increasingly popular hypothesis in ALS research. Indeed, upregulation of neuroinflammatory factors have been observed in both ALS patients and animal models. One such factor is the inflammatory inducer NF-κB. Besides its connection to inflammation, NF-κB activity can be linked to several genes associated to familial forms of ALS, and many of the environmental risk factors of the disease stimulate NF-κB activation. Collectively, this has led many to hypothesize that NF-κB proteins may play a role in ALS pathogenesis. In this review, we discuss the genetic and environmental connections between NF-κB and ALS, as well as how this pathway may affect different CNS cell types, and finally how this may lead to motor neuron degeneration.</description><subject>Alleles</subject><subject>Alzheimer's disease</subject><subject>Amyotrophic lateral sclerosis</subject><subject>Amyotrophic Lateral Sclerosis - etiology</subject><subject>Amyotrophic Lateral Sclerosis - metabolism</subject><subject>Amyotrophic Lateral Sclerosis - pathology</subject><subject>Animal models</subject><subject>Animals</subject><subject>Biomarkers</subject><subject>Cytokines</subject><subject>Degeneration</subject><subject>Disease Susceptibility</subject><subject>Environment</subject><subject>Enzyme Activation</subject><subject>Gene expression</subject><subject>Genetic Predisposition to Disease</subject><subject>Genetic Variation</subject><subject>Humans</subject><subject>Immune system</subject><subject>Infections</subject><subject>Inflammation</subject><subject>Kinases</subject><subject>Localization</subject><subject>Microglia - metabolism</subject><subject>Microglia - pathology</subject><subject>Muscles</subject><subject>Nervous system</subject><subject>Neurodegeneration</subject><subject>Neuromuscular diseases</subject><subject>Neurons</subject><subject>Neurons - metabolism</subject><subject>Neurons - pathology</subject><subject>NF-kappa B - metabolism</subject><subject>NF-κB protein</subject><subject>Oligodendroglia - metabolism</subject><subject>Oligodendroglia - pathology</subject><subject>Paralysis</subject><subject>Proteins</subject><subject>Review</subject><subject>Risk analysis</subject><subject>Risk factors</subject><subject>Roles</subject><subject>Tumor necrosis factor-TNF</subject><subject>Viral infections</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkMFOwzAQRC0EoqVw44wiceFAwF4nsXNBKhUFpAgOlLPlOBua0iQlTkD8Gh_BN-GqpSqcdqV9O5oZQo4ZveA8ppfFrLQAVHIpwh3SZwGAT2kkdrf2HjmwdkYpcAjjfdJzj0zSGPrEm0zRS4rq1Xopth-IlTdMnjxdZd7D2P_-uj4ke7meWzxazwF5Ht9MRnd-8nh7PxomvgkYtL5JYx5yEGA0FxinFGmsM5ll7pBnIhfGsDQSeZQZgybkErjQkWG5CSgPkfEBuVrpLrq0xMxg1TZ6rhZNUermU9W6UH8vVTFVL_W7klRQBuAEztYCTf3WoW1VWViD87musO6sgtCVFIHgwqGn_9BZ3TWVi-eoQEYyjIOlo_MVZZra2gbzjRlG1bJ6tV29w0-2A2zg3675D75afk4</recordid><startdate>20210408</startdate><enddate>20210408</enddate><creator>Källstig, Emma</creator><creator>McCabe, Brian D</creator><creator>Schneider, Bernard L</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1620-0501</orcidid><orcidid>https://orcid.org/0000-0001-5485-8748</orcidid><orcidid>https://orcid.org/0000-0002-2282-5690</orcidid></search><sort><creationdate>20210408</creationdate><title>The Links between ALS and NF-κB</title><author>Källstig, Emma ; McCabe, Brian D ; Schneider, Bernard L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-cb9353272ca37e9b0e09ad8ddcb9fd7f7cc1b67f6dccec538237a6c1fc4035e13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Alleles</topic><topic>Alzheimer's disease</topic><topic>Amyotrophic lateral sclerosis</topic><topic>Amyotrophic Lateral Sclerosis - etiology</topic><topic>Amyotrophic Lateral Sclerosis - metabolism</topic><topic>Amyotrophic Lateral Sclerosis - pathology</topic><topic>Animal models</topic><topic>Animals</topic><topic>Biomarkers</topic><topic>Cytokines</topic><topic>Degeneration</topic><topic>Disease Susceptibility</topic><topic>Environment</topic><topic>Enzyme Activation</topic><topic>Gene expression</topic><topic>Genetic Predisposition to Disease</topic><topic>Genetic Variation</topic><topic>Humans</topic><topic>Immune system</topic><topic>Infections</topic><topic>Inflammation</topic><topic>Kinases</topic><topic>Localization</topic><topic>Microglia - metabolism</topic><topic>Microglia - pathology</topic><topic>Muscles</topic><topic>Nervous system</topic><topic>Neurodegeneration</topic><topic>Neuromuscular diseases</topic><topic>Neurons</topic><topic>Neurons - metabolism</topic><topic>Neurons - pathology</topic><topic>NF-kappa B - metabolism</topic><topic>NF-κB protein</topic><topic>Oligodendroglia - metabolism</topic><topic>Oligodendroglia - pathology</topic><topic>Paralysis</topic><topic>Proteins</topic><topic>Review</topic><topic>Risk analysis</topic><topic>Risk factors</topic><topic>Roles</topic><topic>Tumor necrosis factor-TNF</topic><topic>Viral infections</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Källstig, Emma</creatorcontrib><creatorcontrib>McCabe, Brian D</creatorcontrib><creatorcontrib>Schneider, Bernard L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Källstig, Emma</au><au>McCabe, Brian D</au><au>Schneider, Bernard L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Links between ALS and NF-κB</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2021-04-08</date><risdate>2021</risdate><volume>22</volume><issue>8</issue><spage>3875</spage><pages>3875-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease wherein motor neuron degeneration leads to muscle weakness, progressive paralysis, and death within 3-5 years of diagnosis. Currently, the cause of ALS is unknown but, as with several neurodegenerative diseases, the potential role of neuroinflammation has become an increasingly popular hypothesis in ALS research. Indeed, upregulation of neuroinflammatory factors have been observed in both ALS patients and animal models. One such factor is the inflammatory inducer NF-κB. Besides its connection to inflammation, NF-κB activity can be linked to several genes associated to familial forms of ALS, and many of the environmental risk factors of the disease stimulate NF-κB activation. Collectively, this has led many to hypothesize that NF-κB proteins may play a role in ALS pathogenesis. In this review, we discuss the genetic and environmental connections between NF-κB and ALS, as well as how this pathway may affect different CNS cell types, and finally how this may lead to motor neuron degeneration.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>33918092</pmid><doi>10.3390/ijms22083875</doi><orcidid>https://orcid.org/0000-0003-1620-0501</orcidid><orcidid>https://orcid.org/0000-0001-5485-8748</orcidid><orcidid>https://orcid.org/0000-0002-2282-5690</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1422-0067 |
ispartof | International journal of molecular sciences, 2021-04, Vol.22 (8), p.3875 |
issn | 1422-0067 1661-6596 1422-0067 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8070122 |
source | MDPI - Multidisciplinary Digital Publishing Institute; MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Alleles Alzheimer's disease Amyotrophic lateral sclerosis Amyotrophic Lateral Sclerosis - etiology Amyotrophic Lateral Sclerosis - metabolism Amyotrophic Lateral Sclerosis - pathology Animal models Animals Biomarkers Cytokines Degeneration Disease Susceptibility Environment Enzyme Activation Gene expression Genetic Predisposition to Disease Genetic Variation Humans Immune system Infections Inflammation Kinases Localization Microglia - metabolism Microglia - pathology Muscles Nervous system Neurodegeneration Neuromuscular diseases Neurons Neurons - metabolism Neurons - pathology NF-kappa B - metabolism NF-κB protein Oligodendroglia - metabolism Oligodendroglia - pathology Paralysis Proteins Review Risk analysis Risk factors Roles Tumor necrosis factor-TNF Viral infections |
title | The Links between ALS and NF-κB |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T21%3A24%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Links%20between%20ALS%20and%20NF-%CE%BAB&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=K%C3%A4llstig,%20Emma&rft.date=2021-04-08&rft.volume=22&rft.issue=8&rft.spage=3875&rft.pages=3875-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms22083875&rft_dat=%3Cproquest_pubme%3E2548685941%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2548685941&rft_id=info:pmid/33918092&rfr_iscdi=true |